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Abstract
The regulation of gene transcription is fundamental to the existence of complex multicellular organisms such as humans.
Although it is widely recognized that much of gene regulation is controlled by gene-specific protein-DNA interactions, there
presently exists little in the way of tools to identify proteins that interact with the genome at locations of interest. We have
developed a novel strategy to address this problem, which we refer to as GENECAPP, for Global ExoNuclease-based
Enrichment of Chromatin-Associated Proteins for Proteomics. In this approach, formaldehyde cross-linking is employed to
covalently link DNA to its associated proteins; subsequent fragmentation of the DNA, followed by exonuclease digestion,
produces a single-stranded region of the DNA that enables sequence-specific hybridization capture of the protein-DNA
complex on a solid support. Mass spectrometric (MS) analysis of the captured proteins is then used for their identification
and/or quantification. We show here the development and optimization of GENECAPP for an in vitro model system,
comprised of the murine insulin-like growth factor-binding protein 1 (IGFBP1) promoter region and FoxO1, a member of the
forkhead rhabdomyosarcoma (FoxO) subfamily of transcription factors, which binds specifically to the IGFBP1 promoter. This
novel strategy provides a powerful tool for studies of protein-DNA and protein-protein interactions.
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Introduction
Proteins interact with DNA throughout the genome to control
gene transcription on multiple levels (e.g. chromatin accessibility
and recruitment of transcription machinery) [1]. Cis regulatory
elements, that modulate the transcription of nearby genes,
comprise only a fraction of the known regulatory sites controlled
by transcription factors. Transcription of many genes is controlled
by binding of proteins at distant sites, and a wide variety of
protein-protein interactions within the chromatin provides addi-
tional levels of control by activating, enhancing or repressing
transcription. Histone proteins can control chromatin accessibility
and modulate secondary protein binding to DNA through various
post-translational modifications. In spite of the critical importance
of these protein-DNA interactions, at present few tools exist to
identify and characterize the known and unknown proteins that
interact with chromatin across the genome.
The most powerful technologies currently available employ
chromatin immunoprecipitation, with subsequent analysis on
DNA arrays (ChIP-Chip) [2,3,4,5,6,7] or by DNA sequencing
(ChIP-Seq) [8,9,10] to identify DNA sequences that are directly or
indirectly bound to proteins of interest throughout the genome.
Although very effective and extremely useful, the greatest
limitation of these strategies is their requirement for a specific
antibody directed against the protein of interest. This limits the
approach to characterizing the genome-binding behavior of
already known proteins, and thus does not help to identify new,
previously unknown proteins, nor does it help to reveal the
identities of additional interacting proteins that are associated with
particular genomic regions of interest.
New methods for mass-spectrometric identification of proteins
binding to specific genomic loci are also beginning to emerge
[11,12,13,14,15,16,17]. Early attempts at accomplishing this
involved exposure of synthetic dsDNA as bait to trap specific
DNA-binding proteins from nuclear extract [13,14,16,17]. The
technique of SILAC (Stable Isotope Labeling by Amino acids in
Cell culture) has been used to improve the confidence of such
methods [15]. These ex vivo approaches have an advantage in that
large amounts of DNA and extract can be used to isolate sufficient
material for MS identification. In contrast, in vivo approaches are
considerably more challenging because the DNA sequence of
interest may be present at a level of as few as one copy per cell.
Butala et al [11] were able to achieve successful identification of
proteins from protein-DNA complexes formed in vivo in bacteria
by increasing the abundance of the DNA through clever use of a
low copy number plasmid containing the sequence of interest and
LacI to facilitate extraction. De ´jardin and Kingston [12] used
locked nucleic acid (LNA) probes to isolate genomic DNA with its
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which are highly repetitive regions at the end of chromosomes, to
obtain sufficient material for protein identification. It remains to
be seen if any of these methods can be multiplexed for parallel
analysis of multiple gene sequences. Furthermore, none have yet
demonstrated sensitivity for identification of in vivo bound DNA-
binding proteins when the sequence of interest is present at only a
single copy per cell.
We have developed a novel strategy to attack this problem, a
strategy that is amenable to multiplexing and may offer single-
copy sensitivity. We refer to it as GENECAPP, for Global
ExoNuclease-based Enrichment of Chromatin-Associated Pro-
teins for Proteomics. In this approach, formaldehyde cross-linking
is employed to covalently link DNA to its associated proteins;
subsequent fragmentation of the DNA, followed by exonuclease
digestion, produces a single-stranded region of the DNA that
enables sequence-specific hybridization capture of the protein-
DNA complex on a solid support. Mass spectrometric (MS)
analysis of the captured proteins is then used for their
identification and/or quantification.
We describe here the development and optimization of this
multi-step process for an in vitro model system, comprised of the
murine insulin-like growth factor-binding protein 1 (IGFBP1)
promoter region and FoxO1, a member of the forkhead
rhabdomyosarcoma (FoxO) subfamily of transcription factors which
binds specifically to IGFBP1. We prepared a 180 bp DNA PCR
amplicon containing mouse IGFBP1 promoter sequence and
formed a complex with recombinant FoxO1 protein prior to
covalent cross-linking. This simulates the fragment that will be
produced with fragmentation of native chromatin. Partial
digestion of the FoxO1-IGFBP1 complex with exonuclease
enables sequence-specific capture of the complex on a solid
support grafted with complementary oligonucleotides. FoxO1
protein was subjected to protease digestion directly on the support,
followed by MS analysis. This novel strategy provides a powerful
tool for in vitro studies of DNA-protein and protein-protein
interactions, and lays the foundation for further extensions of the
approach for the comprehensive identification and quantitative
analysis of proteins interacting with DNA in vivo.
Results
Global ExoNuclease-based Enrichment of Chromatin-
Associated Proteins for Proteomics (GENECAPP)
The GENECAPP strategy employs sequence-specific hybrid-
ization capture of a specific DNA fragment to allow the isolation
and subsequent characterization of all proteins bound to that
region (Figure 1, reproduced by permission from The Royal
Society of Chemistry from Lloyd M. Smith, Michael R. Shortreed
and Michael Olivier, Analyst, 2011, 136, 3060–3065, DOI:
10.1039/C1AN15037E) [18]. The first step in the process is the
treatment of cells or tissue with formaldehyde to cross-link proteins
to DNA, as is routinely done in ChIP-Chip/Seq assays. The
chromatin is then fragmented, by either a physical means such as
sonication, or an enzymatic means such as restriction enzyme
digestion. Exonuclease digestion of one of the two strands of the
duplexes protruding from the complex produces a free single-
stranded region suitable for DNA hybridization. Incubation of this
material with a solid support modified with complementary single-
stranded DNA capture probes results in specific binding of the
chromatin fragments of interest along with associated proteins.
Subsequent characterization of these bound proteins by standard
proteomic mass spectrometry techniques permits identification
and/or quantification of proteins that are bound to the targeted
DNA region, and potentially the characterization of posttransla-
tional protein modifications. The approach is amenable to
parallelization by using the multiplex capabilities of either array-
based or bead-based platforms with multiple capture oligonucle-
otide probes that are complementary to targeted DNA regions of
interest. Key steps in this process (cross-linking, exonuclease
digestion, sequence-specific capture and MS protein identification)
were developed and optimized using an in vitro model system
(Figure 2) as described below.
FoxO1-IGFBP1 model system
FoxO1 protein binds to cognate sites within the insulin-like
growth factor-binding protein 1 promoter [19,20]. The sequence
of the 180 bp PCR amplicon containing mouse IGFBP1 promoter
sequences (2204 to 225) is shown in Figure 3A. This region of the
IGFPB1 promoter contains an insulin response element (IRE),
which has two FoxO1 cognate binding sites, and a third FoxO1
‘‘new’’ binding site (FNBS) [20]. Specific binding of recombinant
FoxO1 protein to the PCR amplicon was confirmed by
electrophoretic mobility shift assay (EMSA) (Figure 3B). Two
bands appear in the EMSA when FoxO1 protein is mixed with the
IGFBP1 DNA at a molar ratio of 1.5:1.0 (Figure 3B), correspond-
ing to a 1:1 FoxO1-DNA complex (lower band), and to a 2:1
complex (upper band) [20]. Residual free DNA remains, consistent
with the presence of multiple FoxO1 binding sites in the amplicon.
Increasing the molar ratio of FoxO1 protein to IGFBP1 DNA to
3:1 results in a nearly complete depletion of free DNA and an
increase in the intensity of the band assigned to the 2:1 complex.
There is also increased intensity in the region of the gel above the
second band suggesting that some of the DNA molecules have
three or more proteins associated with them, although no distinct
bands corresponding to such higher binding stoichiometries are
observed. In control experiments using PCR amplicons lacking the
FoxO1 cognate binding sites, no gel shift is observed (data not
shown).
Cross-linking proteins to DNA
Formaldehyde is widely used in ChIP, ChIP-Chip, and ChIP-
Seq experiments to covalently cross-link protein-DNA, protein-
protein and protein-RNA complexes and thereby maintain their
integrity during processing [2,3,4,5,6,7,8,9,10,21,22,23,24,25,
26,27,28,29,30,31]. In order for it to have similar utility in
GENECAPP, it is necessary that it not inhibit subsequent steps in
the process, such as the exonuclease digestion of the DNA. To
evaluate this we first determined the optimal concentration for
formaldehyde cross-linking in the FoxO1-IGFBP1 model system.
The FoxO1-IGFBP1 protein-DNA complex was prepared as
described above and cross-linked for 10 min using various
concentrations of formaldehyde (0.0–1.0% v/v), followed by
quenching of the reaction with Tris (tris(hydroxymethyl)amino-
methane) base (data not shown). The choice of Tris for quenching
[32], as opposed to the more commonly used glycine
[27,28,29,30,31], is discussed below. SDS (sodium dodecyl sulfate),
an anionic surfactant, was added to a final concentration of 2.5%
w/v followed by analysis on a tris-borate-EDTA (TBE) polyacryl-
amide gel. SDS is employed in order to denature any protein
complexes that are not covalently linked by the formaldehyde
treatment. At formaldehyde concentrations up to 0.625%, free
dsDNA is present, whereas at concentrations of 0.75% or higher,
no free DNA was observed, indicating complete cross-linking of
the FoxO1-IGFBP1 complex. Accordingly, a concentration of
0.75% formaldehyde was employed for all subsequent cross-
linking experiments.
Sequence-Specific Capture of Protein-DNA Complexes
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Glycine is commonly used to quench formaldehyde cross-linking
reactions in chromatin immunoprecipitation (ChIP) studies
[27,28,29,30,31]. We found that DNA exposed to formaldehyde
and then quenched with an equimolar amount of glycine, as is
commonly done, becomes non-digestible by E. coli exonuclease III,
which is a critical step in creating the single-stranded regions of
DNA necessary for sequence-specific capture of the protein-DNA
complex. 6-carboxyfluorescein (FAM)-labeled IGFBP1 dsDNA was
treated with 0.75% formaldehyde at room temperature for 10 min.
The solution was divided into three aliquots, one of which was kept
as a non-quenched control, one was Tris-quenched, and the third
was glycine-quenched. The buffer in all samples was exchanged for
exonuclease III reaction buffer followed by exonuclease digestion.
The digestion reaction was stopped after 0, 5 and 15 min by
addition of EDTA, and the reaction products were both fragment
length-analyzed (Figure 4, and Figures S1, S2, S3, S4) and
characterized with respect to their hybridization to DNA tiling
arrays (see below and Figures S5, S6, S7, S8). Exonuclease digestion
of untreated DNA, formaldehyde treated DNA and formaldehyde-
treated/Tris-quenched DNA produced very similar digestion
product profiles on the gene sequencer. In contrast, the digestion
product profile of the formaldehyde-treated and glycine-quenched
DNA indicated a nearly complete absence of digestion.
Exonuclease digestion of DNA and protein-DNA
complexes
E. coli exonuclease III is a 39 to 59 exonuclease specific for
double-stranded DNA [33,34]. It is possible to obtain fine control
over the digestion rate by controlling the enzyme dose, reaction
time and temperature. We developed a DNA tiling array-based
strategy (Figure 5) to characterize the products of the exonuclease
digestion reaction. This allowed us to optimize the generation of
single-stranded DNA for sequence-specific capture on the array.
We fabricated an oligonucleotide tiling array containing all
possible 19 mer complements, thereby spanning the entire
180 bp long IGFBP1 DNA in 162 single-base increments. The
fluorescence signal that is observed necessarily arises from a partial
duplex because the 59-terminal FAM tag utilized for fluorescence
detection is not on the DNA strand that directly hybridizes to the
surface-bound capture probe. Fluorescence signal from each array
element provides a measurement of the amount of digested duplex
capturable by specific complementary oligonucleotides and was
expected to vary with the degree of digestion. The integrated
fluorescence signal summed from all features on the array provides
a measure of the total amounts of capturable duplex allowing
comparison between various treatment conditions. The digestion
products were also analyzed by DNA fragment length analysis on
a DNA sequencer (see Methods section), which provided
quantitative information on the product length profile.
We profiled the digestion of two different IGFBP1 targets (pure
IGFBP1 DNA and IGFBP1 DNA covalently cross-linked to
FoxO1 protein with formaldehyde and quenched with Tris).
Exonuclease III digestion of 100 ng pure IGFBP1 DNA by either
2 units of exonuclease III at room temperature for 1 min
(Figure 6A) or by 0.2 units of exonuclease III at room temperature
for 15 min (Figure S9) produced similarly large amounts of
capturable duplex and relatively even digestion profiles (Figures 6,
S1 and S9). Digestion of formaldehyde cross-linked and Tris-
Figure 1. Schematic diagram of GENECAPP, for Global ExoNuclease-based Enrichment of Chromatin-Associated Proteins for
Proteomics. In this illustration of the process, formaldehyde cross-linked chromatin is fragmented (e.g. sonication or restriction endonuclease) into
small, nucleosome-length pieces. Fragments are treated with exonuclease to produce single-stranded regions, which are used for sequence-specific
capture on a complementary DNA oligonucleotide array. Protease digestion of the captured complexes yields sample for MS analysis; enabling
identification of the proteins and subsequent association of those proteins with genomic loci. Reproduced by permission from The Royal Society of
Chemistry from Lloyd M. Smith, Michael R. Shortreed and Michael Olivier, Analyst, 2011, 136, 3060–3065, DOI: 10.1039/C1AN15037E.
doi:10.1371/journal.pone.0026217.g001
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digestion time to between 15 and 45 minutes and an increase in
reaction temperature to 37uC (Figure 6B). Higher or lower doses
of exonuclease III generated lower amounts of capturable duplex
presumably because of over- or under-digestion respectively.
Similarly, longer reaction times resulted in over-digestion of both
the pure duplex DNA (Figure S9) and the protein-DNA complex
(Figure S10). The fragment length analysis data supported
conclusions drawn from the tiling array analysis (Figures S11,
S12, S13, S14, S15)
Sequence-specific capture of FoxO1-IGFBP1 complex
The sequence-specific capture of exonuclease digested FoxO1-
IGFBP1 complex was demonstrated on the DNA tiling arrays
(Figure 6). Several non-complementary probe oligonucleotides
were included on each array to monitor non-specific binding,
which was found to be negligible. A major advantage of the tiling
array is that the hybridization efficiency of many different capture
probe sequences can be compared directly with one another,
allowing identification of the best probe sequence for capture of
the complex.
The digested FoxO1-IGFBP1 complex bound most strongly to
the end (first) oligonucleotide complement in the tiling array
(Figure 6B). Further testing of the capture on array substrates
covered entirely with a uniform layer of that complementary
capture probe permitted a determination of the capacity of the
surface to bind the protein-DNA complex (Figure 7). The
oligonucleotide-modified substrate was treated sequentially with
increasing concentrations of the FAM-labeled FoxO1-IGFBP1
complex. The surface was then rinsed briefly to remove any of the
complexes that had not hybridized to the surface. An 8 M urea
solution was used to denature the hybridization between the
Figure 2. A model system for GENECAPP. FoxO1-IGFBP1 protein-DNA complex is formed in solution and cross-linked with formaldehyde prior to
buffer exchange and exonuclease III digestion. The digestion produces 59 single-stranded DNA overhangs for capture by hybridization on an in situ
synthesized oligonucleotide array. The captured protein-DNA complexes are denatured using urea, protease digested either directly on the substrate
or in solution, and then analyzed by MS. Initial experiments comparing on-chip versus in-solution digestion yielded little or no MS signal for the latter
case; thus, we employed only on-chip digestion in all work reported herein.
doi:10.1371/journal.pone.0026217.g002
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the amount of fluorescence was compared to fluorescence
measured on a series of standard solutions prepared by mixing
known amounts of the fluorescent complex with 8 M urea. The
amount of complex captured compared with the amount applied is
plotted in Figure 7. The amount of material captured levels off at
about 0.33 pmol/cm
2, and application of more than 1.5 pmol/
cm
2 yields no further increase in the amount captured. The
capture efficiency can be calculated from the data in Figure 7 by
dividing the amount of complex captured on the surface by the
amount of complex that was applied. The maximum capture
efficiency was slightly greater than 25% for the case where
1.5 pmol of complex was applied to the surface. The absolute
amount of material captured was slightly larger when more
complex was applied, but with a lower relative efficiency.
Mass spectrometric protein identification and
quantification
Captured FoxO1-IGFBP1 complex was digested with trypsin
and analyzed by mass spectrometry. For discovery-based analysis
(i.e. identification of unknown proteins), digests were analyzed on a
linear ion trap/Orbitrap tandem mass-spectrometer operating in
data-dependent acquisition (DDA) mode. For targeted, quantita-
tive analysis, samples were analyzed on a triple-quadrupole/linear
Figure 3. IGFBP1 promoter sequence and FoxO1 binding assay. (A) The 180 bp mouse IGFBP1 promoter sequence (2204 to 225) contains
three FoxO1 binding sites, two within the IRE (insulin response element) and one new binding site designated FNBS. This promoter fragment also
contains a binding site for the transcription factor HNF-1 (hepatocyte nuclear factor 1) and two binding sites for GR (glucocorticoid receptor). (B)
Electrophoretic mobility shift assay (EMSA) confirms specific binding of recombinant FoxO1 protein to the PCR amplicon. The band in lane one
corresponds to free IGFBP1 DNA. Two new bands, indicated by the arrows, appear in lane two when FoxO1 protein is mixed with the IGFBP1 DNA at a
molar ratio of 1.5:1.0 corresponding to the formation of the 1:1 and 2:1 FoxO1-IGFBP1 protein-DNA complex. Increasing the molar ratio of FoxO1
protein to IGFBP1 DNA to 3.0:1.0 results in a nearly complete depletion of free DNA and an increase in the intensity of the band assigned to the 2:1
complex.
doi:10.1371/journal.pone.0026217.g003
Figure 4. Fragment length analysis of exonuclease-digested DNA. The effect of cross-linking and quencher type was evaluated by profiling
the exonuclease digestion products of FAM-labeled 180 bp IGFBP1 DNA: (A) untreated DNA control; (B) DNA cross-linked with 0.75% (v/v)
formaldehyde; (C) DNA cross-linked with 0.75% (v/v) formaldehyde, followed by quenching with 250 mM Tris; and, (D) DNA cross-linked with 0.75%
(v/v) formaldehyde, followed by quenching with 250 mM glycine.
doi:10.1371/journal.pone.0026217.g004
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isotopically heavy labeled FoxO1 peptides spiked into samples to
serve as internal standards. The signal from the respective heavy
and light FoxO1 peptide SRM transitions were used to calculate
the amount of protein in each sample. Both types of analysis
yielded positive results, providing both robust identification (via
decoy/target database searching with SEQUEST algorithm and
filtration to a 1% false discovery rate) and quantification (see
below) of FoxO1 protein.
The effect of formaldehyde cross-linking and its reversal upon
mass spectrometric identification or quantification of the FoxO1
protein was evaluated. A 3:1 mixture of FoxO1 and IGFBP1
DNA was prepared and split into parts for three treatments: (1)
untreated, (2) formaldehyde cross-linked, and (3) formaldehyde
cross-linked followed by cross-linking reversal. The reverse cross-
linking step was performed by heating at 99uC for 25 minutes in
a reverse cross-link buffer [12] containing 250 mM Tris, pH 8.8,
0.5 M b-mercaptoethanol, and 1% RapiGest,a nM S - c o m p a t i b l e
detergent substituting for SDS. The efficacy of these cross-linking
reversal conditions was confirmed by DNA mobility analysis on a
polyacrylamide gel (data not shown). Both SRM and DDA
analysis showed little difference in the amount of FoxO1 protein
detected between non-cross-linked and cross-linked samples
(SRM data shown in Figure 8 and Tables S1, S2 and S3). This
indicates that cross-linking has little or no adverse effect on the
ability to quantify FoxO1 in the FoxO1-IGFBP1 complex.
However, after the cross-linking reversal step, detected FoxO1
amounts were significantly reduced, suggesting that the condi-
tions employed compromise protein detection, perhaps due to
some combination of protein degradation, chemical modification,
or precipitation (Figure 8). In view of these results, we decided to
eliminate the cross-linking reversal step from the process, as it
unnecessarily decreased protein signal, and provided no apparent
benefit.
MS analysis of FoxO1-IGFBP1 complex captured on a
solid support
We demonstrated the identification and quantification of
FoxO1 protein from samples treated using the optimized
GENECAPP process. FoxO1-DNA complexes were formed in
solution, cross-linked with formaldehyde, quenched with Tris
base, digested with exonuclease III and captured on a solid
support grafted with complementary oligonucleotides. The
surface-captured FoxO1-IGFBP1 complexes were digested on
the solid support using an on-chip tryptic digestion procedure,
which included incubation in concentrated urea to release the
FoxO1-IGFBP1 complex from the surface and simultaneously
denature FoxO1. Each sample was spiked with heavy labeled
FoxO1 peptide standard and assayed by SRM, enabling accurate
quantification of the amount of FoxO1 captured on the non-
Figure 5. Schematic of tiling array design. An oligonucleotide tiling array containing all possible 19 mer complements, spanning the entire
180 bp long IGFBP1 DNA in 1 base steps, was fabricated using a maskless array synthesizer. The array was designed so that three quality control (non-
complementary) sequences were placed directly in the center of the array. Probe one, which is complementary to the first 19 nt of the IGFBP1 DNA,
was also located in the center of the array. The second probe, complementary to nucleotides 2–20, was placed directly to the right of probe one.
Placement of additional probes proceeded in a clockwise spiral as shown by the red arrow. A second series of quality control and probe sequences
were placed on the array beginning immediately after the first series was completed continuing in the clockwise spiral. FAM labeled protein-DNA
complexes were pre-formed and partially digested by exonuclease III before being applied onto the tiling array for hybridization.
doi:10.1371/journal.pone.0026217.g005
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supports. As for the reverse-cross-linking experiments, each of
these samples were also run on a linear ion trap/Orbitrap
tandem mass-spectrometer in DDA mode and discovery results
correlated well with SRM findings (data not shown). Substrates
grafted with the complementary DNA probe oligonucleotide
yielded approximately three-fold as much FoxO1 protein
(94 fmol) as substrates with a non-complementary probe
(32 fmol) (Figure 9). The FoxO1 levels in the FoxO1-IGFBP1
solution applied to each solid support were also determined and
used to calculate capture recoveries of 16% and 5.4%,
respectively.
Figure 6. Tiling array profiles of exonuclease digested DNA. (A) The digestion profile of control FAM-labeled IGFBP1 DNA treated for 0, 1, 2, 5
and 15 min with exonuclease III at room temperature (25uC) is visualized by application of the product solution onto DNA tiling arrays and imaging
the chip on a fluorescence scanner. The line profile directly below the tiling array images contains average intensities for the first 90 of 162 unique
array features. Fluorescence signal from the remaining features was at background levels. (B) The digestion profile of the cross-linked and Tris-
quenched FoxO1-FAM-labeled IGFBP1 DNA treated for 0, 15, 45 and 120 min with exonuclease III (37uC). Contrary to the digestion on free DNA, there
is wide time window to digest cross-linked protein-DNA complex.
doi:10.1371/journal.pone.0026217.g006
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We have developed and optimized a multistep process,
GENECAPP, for the DNA sequence-based hybridization capture
and mass spectrometric analysis of cross-linked protein-DNA
complexes. Details of the process, as applied to an in vitro model
protein-DNA complex, are discussed below.
Cross-linking FoxO1 Protein to IGFBP1 DNA
A covalent bond between protein and DNA can preserve the
specific binding relationship between the two molecules through-
out several processing steps. For example, proteins are cross-linked
to DNA in ChIP-Chip/Seq experiments prior to fragmentation of
the chromatin. It is then possible to extract the relevant DNA
fragments by immunoprecipitation of the target protein. Here,
sequence-specific capture of the DNA is used to extract the desired
complexes from solution, and cross-linking enables the associated
proteins to remain attached to the DNA during the extraction and
subsequent processing steps.
Formaldehyde offers several unique advantages as a cross-linker
[21,22,28]. It rapidly permeates cell walls and membranes,
covalently connects nucleophiles, weak and strong, which are
ubiquitous in biological systems, and the cross-linking can be
reversed if desired [21]. Formaldehyde is a reasonably specific
cross-linking agent, in spite of its ability to form connections
between essentially any nucleophile-containing molecules. This
specificity arises from its very small size (,2A ˚), as only molecules
that come into very close contact (e.g. specific protein-protein and
protein-DNA complexes) can be cross-linked.
The general mechanism of formaldehyde cross-linking is shown
in Figure 10. The first step is the reaction between formaldehyde
and a relatively strong nucleophile, usually a primary amine,
followed by dehydration of the methylol intermediate to yield an
active Schiff-base. The second step of cross-linking is the reaction
between this Schiff-base and another nucleophile, which can be a
relatively weak one such as the amino group of a nucleic acid base.
Through this two-step mechanism, formaldehyde is able to couple
adjacent nucleophiles such as those found in the binding region of
a protein-DNA complex.
FoxO1-IGFBP1 protein-DNA complexes were treated with
increasing concentrations of formaldehyde during optimization of
the cross-linking reaction and analyzed by polyacrylamide gel
electrophoresis (data not shown). Low concentrations (below
0.375%) of formaldehyde were insufficient to covalently link all of
the DNA duplexes in solution to protein molecules. At 0.375%
formaldehyde the free DNA begins to disappear. We chose
0.75% formaldehyde as the optimum concentration, because it
was the lowest concentration necessary for complete absence of
free DNA. It is likely that the concentration of formaldehyde
necessary for cross-linking in vivo will differ from the amount used
here.
Figure 7. Capture of cross-linked FoxO1-IGFBP1 protein-DNA
complex on a photolithographically-fabricated DNA array. Error
bars correspond to the standard deviation of two replicate experiments.
doi:10.1371/journal.pone.0026217.g007
Figure 8. Normalized amount of FoxO1 protein detected by MS following cross-linking and cross-linking reversal. FoxO1-IGFBP1
protein-DNA complexes were prepared in solution at a 3:1 molar ratio. One sample of the complex was cross-linked with formaldehyde. An aliquot of
this sample was subsequently treated to reverse the cross-links (see Methods section). The MS signal obtained by SRM analysis of an untreated
control sample was nearly equivalent to the MS signal from the cross-linked sample indicating that the cross-linking had only a limited effect.
However, the MS signal obtained by SRM analysis of the cross-link reversed sample was considerably lower than either, indicating a loss of signal
resulting from the cross-linking reversal procedure. Each sample was prepared in duplicate and then analyzed three separate times (technical
replicates). Error bars in the graph represent one standard deviation calculated from those six results.
doi:10.1371/journal.pone.0026217.g008
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Glycine is commonly used to quench formaldehyde reactions in
ChIP-Chip/Seq studies [7,10]. It is thought that glycine stops
cross-linking by reacting both with formaldehyde and with any
active Schiff-base moieties (i.e. both Steps 1 and 2 in Figure 10). In
the first case, glycine plus formaldehyde would form a Schiff-base,
which then could react with another glycine. In the second case,
Schiff-bases already formed on protein molecules could react with
glycine, thereby preventing a cross-link between that protein and
other protein or DNA molecules.
We found that DNA treated with formaldehyde and quenched
with glycine was not digestible with exonuclease III (Figure 4 and
Figures S1, S2, S3, S4, S5, S6, S7, S8). We speculate that glycine
reacts with formaldehyde to form active Schiff-bases, which then
react with the weak nucleophiles found on the DNA bases. This
sequence of reactions decorates the DNA with glycine molecules
and renders it unsuitable as a substrate for exonuclease III.
Fortunately, an alternative reagent is Tris base [32], which
quenches formaldehyde cross-linking while retaining the digest-
ibility of the DNA. Glycine and Tris both contain a primary amine
to react with formaldehyde, but Tris also has additional
nucleophiles (hydroxyl groups) to react with the Schiff-bases
(Figure 11). This highly favorable intramolecular reaction causes
Schiff-bases formed from Tris to be consumed internally and thus
not react to produce any modifications of DNA molecules. This
hypothesis is consistent with our results showing that Tris
quenching of formaldehyde cross-linking has a negligible effect
on exonuclease III activity (Figure 4).
Exonuclease digestion of dsDNA
Commercially available exonucleases, which could potentially
be employed to generate single-stranded DNA for capture by
hybridization, include lambda exonuclease, T7 exonuclease and E.
coli exonuclease III. Lambda exonuclease, a highly processive 59
exonuclease [35,36], proved to be inconsistent and inefficient in
our preliminary experiments (data not shown). T7 exonuclease has
the ability to remove 59 mononucleotides from duplex DNA,
which would have removed the fluorescent tag from our model
DNA and thus prevented us from visualizing it. Therefore, it was
not used in these studies. E. coli exonuclease III is a 39 to 59
exonuclease specific for double-stranded DNA [33,34]. It has been
shown to have relatively low processivity and a uniform digestion
rate [36,37]. By controlling the enzyme dose, reaction time and
temperature, we were able to obtain a high degree of control over
the exonuclease III digestion rate (Figure 6), and thus it was
selected for use.
The use of DNA tiling arrays provided an excellent means to
profile the products of the exonuclease digestion (Figure 5). We
profiled the digestion of two different IGFBP1 targets (pure
IGFBP1 DNA and IGFBP1 DNA covalently cross-linked to
FoxO1 protein with formaldehyde and quenched with Tris). We
tested several different reaction temperatures, reaction times and
enzyme dosages for the three different targets. Data for all tested
conditions is included in the supporting information and two
illustrative data sets are shown in Figure 6. Exonuclease III
rapidly digests the pure IGFBP1 DNA at room temperature
(Figure 6A). However, the cross-linked and Tris-quenched
FoxO1-IGFBP1 complex is much more resistant to digestion.
Increased digestion temperatures and times are required to
produce the single-stranded DNA necessary for sequence-specific
capture (Figure 6B). It is also notable that digestion ceased at
approximately position 40 in the sequence (nucleotides 40–58),
which is adjacent to one of the FoxO1 binding sites. This is
consistent with blocking of the enzyme digestion by the bound
protein, as is commonly observed in DNase footprinting studies
[19,20].
Sequence-specific capture of protein-DNA complexes
Sequence-specific hybridization capture is a critical component
of this work. There are many types of solid supports and
oligonucleotide immobilization chemistries that can be employed
for hybridization capture. In the present work, we employed DNA
microarrays fabricated on glass using a maskless array synthesizer
(MAS) [38]. A major advantage of the MAS is that it permits
synthesis of as many as 786,432 different oligonucleotides on a
161.4 cm chip, providing a high degree of versatility and control.
Figure 10. The general mechanism of formaldehyde cross-linking.
doi:10.1371/journal.pone.0026217.g010
Figure 9. FoxO1 recovered from surfaces with complementary
and non-complementary capture sequences.
doi:10.1371/journal.pone.0026217.g009
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used for analysis of exonuclease digestion and much simpler
surfaces consisting of a single capture probe (or control probe) to
maximize capture capacity.
The tiling array proved useful for identifying which of the many
different 19 mer complementary oligonucleotides yielded the
highest amount of binding to the partially single-stranded
protein-DNA complex. There is an advantage to directly testing
hybridization behavior in this manner because some of the
behavior is not readily predictable. For example, the plots of
fluorescence intensity from captured fluorescent complex clearly
show some structure (Figure 6). There is a high intensity peak for
DNA hybridization of the exonuclease-digested IGFBP1 DNA to
the 26
th complementary probe (Figure 6A). We expected initially
that the relative intensity of the hybridization signals to different
surface-bound complements would correlate with the free energy
of the duplex formed between the complement on the surface and
the digested DNA. However, we found little correspondence
between the two, indicating that other factors (as yet unidentified)
play an important role in the binding process, and underscoring
the need for empirical determinations to identify optimal
sequences for hybridization capture.
On-chip protease digestion and mass spectrometry
analysis
As described in the Results section above, we found that the
FoxO1-IGFBP complexes captured by sequence-specific hybrid-
ization on MAS chips could be digested by trypsin directly on the
substrate surface, eliminating the need for removing the sample
from the solid-support prior to protease digestion. Both identifi-
cation and quantification of captured protein were demonstrated.
Conclusion
We have described here a novel strategy for the Global
ExoNuclease-based Enrichment of Chromatin-Associated Pro-
teins for Proteomics, or GENECAPP. GENECAPP is a multi-step
process for the mass spectrometric identification and quantifica-
tion of DNA-associated proteins. In this proof-of-principle study
we utilized the binding between FoxO1 and the IGFBP1 promoter
region as a model system for technology development. The
FoxO1-IGFBP1 complexes were formed in vitro, and cross-linked
with formaldehyde. Tris was added to quench excess formalde-
hyde and active Schiff base intermediates. Exonuclease III was
used to create single-stranded overhangs for capture by
hybridization on a photolithographically-fabricated DNA array,
followed by on-chip tryptic digestion. The tryptic peptides were
analyzed by LC-MS/MS on both a linear ion trap/Orbitrap
mass-spectrometer (for protein identification) and a triple
quadrupole/linear ion trap mass spectrometer (for quantitative
SRM analysis). Reaction conditions for each step were optimized,
including preparation of the protein-DNA complex, formalde-
hyde cross-linking, quenching, exonuclease digestion, surface
capture, protease digestion, and mass spectrometry analysis. The
specific hybridization capture of FoxO1 protein was demonstrat-
ed and mass spectrometric protein identification and quantifica-
tion were successfully performed.
Materials and Methods
FoxO1 protein and IGFBP1 promoter region complex
preparation
FoxO1 protein was purified as a His10-tagged recombinant
protein from E. coli as described previously [20]. The DNA
fragment corresponding to positions 2205 to 225 of the mouse
IGFBP1 promoter was amplified by PCR from NIH 3T3 (mouse
embryonic fibroblast cell line) genomic DNA (purchased from
New England Biolabs, MA, USA; we used no cell lines in this
work) using the primers (59–TTA GCT CCT GTC CCA GTC
CAT-39 and 59–TAT GAA GGG CTG GCT GTG C–39). A 6-
carboxyfluorescein (FAM) tagged oligonucleotide (59–FAM-TTA
GCT CCT GTC CCA GTC CAT-39) was used to produce a
180 bp fluorescently tagged IGFBP1 promoter DNA amplicon
(Text S1). All primers were custom synthesized by IDT (Integrated
DNA Technologies, IA, USA). The amplicon was gel purified
using the Promega Wizard SV Gel and PCR Clean-up System
(Promega, WI, USA) prior to protein-DNA complex formation.
Binding reactions of FoxO1 protein to IGFBP1 promoter DNA
were performed in final buffer conditions of 10 mM Tris-HCl,
pH 7.5, 1 mM MgCl2, 5 mM DTT, 40 mM KCl, 0.5% glycerol,
1 mg/mL BSA, and 1% Ficoll at room temperature for 1 h. A
typical binding reaction was performed with 10 pmol DNA
(,1200 ng) and 30 pmol FoxO1 protein in 100 mL binding buffer.
Formation of the complexes was verified by electrophoretic
mobility shift assay (EMSA). SYBR Gold nucleic acid gel stain
(Invitrogen, OR, USA) was used to stain DNA in Tris-borate
EDTA polyacrylamide gels.
Formaldehyde cross-linking and quenching
Freshly prepared FoxO1-IGFBP1 complex was cross-linked by
formaldehyde (Pierce, IL, USA) for 10 min at 25uC. A 0.75% (v/
v) final concentration of formaldehyde was used in all cross-linking
reactions unless otherwise stated. Excess formaldehyde and active
Schiff-base intermediates were quenched by addition of Tris,
pH 8.0 to a final concentration of 250 mM followed by incubation
at room temperature for 10 min. Glycine was tested as a quencher
in a similar fashion.
Formaldehyde cross-linking reversal
Formaldehyde cross-links were reversed by incubation at 99uC
for 25 min in 250 mM Tris, pH 8.8, 0.5 M b-mercaptoethanol,
Figure 11. Quenching of formaldehyde cross-linking by Tris. The Schiff-base intermediate, formed from Tris’s primary amine and
formaldehyde, is attacked by the neighboring hydroxyl group to form a highly favored 5-membered ring. This sequence of reactions is repeated to
form a second ring and produce the stable end product, 1-aza-3,7-dioxabicyclo[3.3.0]octane-5-methanol.
doi:10.1371/journal.pone.0026217.g011
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TM SF Surfactant (Waters, MA, USA). These
cross-linking reversal conditions were adapted from a previous
report [12,21]. We used 1% RapiGest
TM SF surfactant as a
replacement for 2% sodium dodecyl sulfate so that the solution
would be compatible with mass spectrometry.
Buffer exchange and exonuclease digestion
The cross-linked and quenched solution of FoxO1-IGFBP1
complex was desalted three times using a cellulose-based 10,000
molecular weight cut-off Amicon Ultra-0.5 mL centrifugal filter
(Millipore, MA, USA) prior to exonuclease III digestion.
Recovery efficiencies were typically higher than 95% (data not
shown). Note: the glycine-quenched protein-DNA complex was
not compatible with purification using the Amicon Ultra-0.5 mL
filter due to a large loss of sample in the filter (data not shown).
The desalted DNA or protein-DNA complex was volume
adjusted to ,12 ng/mL in a final buffer of 10 mM Bis-Tris-
propane-HCl, pH 7.0, 10 mM MgCl2 and 1 mM DTT. Two
units of E. coli exonuclease III (NEB, MA, USA) were used to
digest 100 ng IGFBP1 promoter DNA (180 bp) for 1 min at
25uC or FoxO1-IGFBP1 promoter protein-DNA complex for
45 min at 37uC unless otherwise stated. Exonuclease III
digestions were stopped by addition of EDTA to a final
concentration of 25 mM. Lambda exonuclease (NEB, MA,
USA) and T7 exonuclease (T7 Gene 6 Exonuclease, Affymetrix,
CA, USA) were used in DNA digestion comparison experiments.
The extent of digestion was monitored on DNA tiling arrays or
by fragment length analysis on a 3730xl DNA analyzer (Applied
Biosystems, CA, USA).
In situ photolithographic oligonucleotide array design
and synthesis
Glass microscope slides (Plain Micro Slides, VWR, PA, USA)
were cleaned with 1 M sodium hydroxide prior to silanization.
The slides were then silanized for 4 h in 2% (v/v) N-(2-
triethoxysilylpropyl)-4-hydroxy-butyramide (Gelest, Inc., Morris-
ville, PA, USA) in stock solution (0.1% acetic acid in 95%
ethanol). After being rinsed by stirring in fresh stock solution for
15 min, the slides were transferred to a pre-heated (120uC) oven
for 2 h, and cured under vacuum overnight. Light-directed
photolithographic synthesis was performed on the silanized glass
slides with a digital micromirror-based Maskless Array Synthesis
(MAS) system connected to a ABI Expedite
TM 8909 Nucleic Acid
Synthesis System (Applied Biosystems, CA, USA) as described
previously [38,39,40]. Table S4 contains the probe sequences
synthesized on the surface. All the oligonucleotides were
synthesized in situ in the 39R59 direction on the silanized glass.
A 15-thymidine spacer, which has been shown to increase
hybridization efficiency [41,42], was included at the 39 end of
every oligonucleotide. Each of the tiling arrays was composed of
334 features, sized 130 mm6130 mm, and separated by 50 mm.
The size of the capture and negative control arrays was
1.4 mm61.0 mm.
Capture and detection on oligonucleotide arrays
Exonuclease III digested FAM-tagged IGFBP1 promoter DNA
and FoxO1-IGFBP1 complexes were supplemented with 106
SSPE buffer to give a final 16 SSPE concentration (10 mM
NaH2PO4, 150 mM NaCl, 1 mM EDTA, pH 7.4) before
application to the oligonucleotide arrays. The hybridization
reaction was performed in a humid chamber at room temperature
for 3 h. The surfaces were then rinsed and incubated in 16SSPE
buffer at 37uC for 15 min to remove nonspecifically bound DNA
and protein-DNA complexes. Images of fluorescence were
obtained using a GeneTac UC 464 microarray scanner (Genomic
Solutions, MI, USA).
Determination of surface binding capacity
A ten-fold molar excess of FoxO1 protein was added to FAM-
tagged IGFBP1 promoter DNA to ensure the complete absence of
free DNA. The complexes were formaldehyde cross-linked, Tris
quenched and buffer exchanged with exonuclease III working
buffer before digestion. The complexes were then exonuclease III
digested based on a ratio of 2 units of exonuclease III for 100 ng
FAM-tagged 180 bp IGFBP1 promoter DNA. Various amounts of
the complexes were applied to the IGFBP1 capture tiling array for
hybridization capture. Nonspecifically-bound complexes were
removed by incubating the surface in 16SSPE buffer at 37uC for
15 min. The captured complexes were then eluted by incubating
the surface in 8 M urea at room temperature for 30 min. The
capture capacity of the array was determined using a previously
published wash-off method [43]. The fluorescence intensities of the
solutions containing fluorescent complexes that were eluted from
the surface with urea were compared to calibration solutions
containing known amounts of the fluorescent complex (10
211 to
10
28 M) to determine the number of moles of complex recovered
from the surface. The amount recovered from the surface divided
by the surface area was reported as the binding capacity.
On-chip protease digestion and analysis by mass
spectrometry
On-chip protease digestion of captured FoxO1 protein was
performed after thoroughly rinsing the array surfaces to remove any
non-specifically bound complex. A 20 mL aliquot of 8 M urea in
50 mM ammonium bicarbonate buffer at pH 8.0 was applied to the
array. The sample was incubated for 30 min at room temperatureto
elute the DNA from the surface and to denature the FoxO1 protein.
The solution on the surface was then diluted ten-fold with 50 mM
ammonium bicarbonate buffer to lower the urea concentration to
,1 M. Sequence grade modified trypsin (Promega, WI, USA) was
added at a final protease:protein ratio of 1:20 (w/w) based on the
original FoxO1 input. The on-chip tryptic digestion was carried out
in a humid chamber at 37uC overnight. For SRM analysis, two C-
terminalheavylabeled FoxO1 proteotypic peptides,which were pre-
selected (Table S1) and synthesized (Ulm, ThermoFisher Scientific,
Germany), were spiked directly into the mixture on-chip in known
amounts. Each sample was then purified using OMIX C18 pipette
tips (Varian, CA, USA) before analysis by mass spectrometry. SRM
samples were separated on a nanocapillary column using a
nanoACQUITY UPLC system (Waters, MA, USA). All columns
were prepared in-house and packed with MAGIC C18AQ
stationary phase (Michrom Bioresources, CA, USA). The sample
was nanosprayed into an AB SCIEX QTRAP 5500 triple
quadrupole mass spectrometer (AB SCIEX, CA, USA), which
monitored multiple heavy and light transitions per peptide pair for
quantification. Samples were also analyzed on an LTQ Oribitrap
Velos mass spectrometer (Thermo Scientific, FL, USA) in discovery
mode and peptides were identified with Proteome Discoverer
software. False discovery rate determinations were performed using
the Proteome Discoverer software Decoy Database Search.
Supporting Information
Figure S1 Fragment length profile from digestion of
dsDNA with exonuclease III as a function of time. Two
units of exonuclease III were used to digest 100 ng of FAM-labeled
IGFBP1 DNA for 0, 5 and 15 min at room temperature.
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final concentration of 25 mM. The samples were subjected to
fragment analysis using an ABI 3130xl Genetic Analyzer (Applied
Biosystems, CA, USA).
(TIF)
Figure S2 Fragment length profile from digestion of
formaldehyde-treated dsDNA with exonuclease III as a
function of time. FAM-labeled 180 bp IGFBP1 DNA was
pretreated with 0.75% (v/v) formaldehyde for 10 min. The excess
formaldehyde was diluted and buffer exchanged before exonucle-
ase III digestion. Two units of exonuclease III were used to digest
the DNA for 0, 5 and 15 min at room temperature. After
digestion, the samples were subjected to fragment analysis using an
ABI 3130xl Genetic Analyzer (Applied Biosystems, CA, USA).
(TIF)
Figure S3 Fragment length profile from digestion of
formaldehyde-treated and Tris-quenched dsDNA with
exonuclease III as a function of time. The effect of cross-
linking reagent (formaldehyde) and Tris quencher was evaluated
by profiling the exonuclease digestion products. FAM-labeled
180 bp IGFBP1 DNA was pretreated with 0.75% (v/v) formal-
dehyde for 10 min, followed by quenching with 250 mM Tris.
The formaldehyde and Tris were diluted and buffer exchanged.
Two units of exonuclease III were used to digest the DNA for 0, 5
and 15 min at room temperature. After digestion, the samples
were subjected to fragment analysis using an ABI 3130xl Genetic
Analyzer (Applied Biosystems, CA, USA).
(TIF)
Figure S4 Fragment length profile from digestion of
formaldehyde-treated and glycine-quenched dsDNA
with exonuclease III as a function of time. The effect of
cross-linking reagent (formaldehyde) and glycine quencher was
evaluated by profiling the exonuclease digestion products. FAM-
labeled 180 bp IGFBP1 DNA was pretreated with 0.75% (v/v)
formaldehyde for 10 min, followed by quenching with 250 mM
glycine. The formaldehyde and glycine were diluted and buffer
exchanged. 2 units of exonuclease III were used to digest the DNA
for 0, 5, and 15 min at room temperature. After digestion, the
samples were subjected to fragment analysis using an ABI 3130xl
Genetic Analyzer (Applied Biosystems, CA, USA).
(TIF)
Figure S5 Fragment length profile from digestion of
dsDNA with exonuclease III as a function of time. Two
units of exonuclease III were used to digest FAM-labeled IGFBP1
DNA for 0, 5 and 15 min at room temperature. The digestion
profile was visualized by application of the product solution onto
DNA tiling arrays and imaging the substrate on a fluorescence
scanner. The line profile directly below the tiling array images
contains average intensities for the first 90 of 162 unique array
features. Fluorescence signal from the remaining features was at
background levels.
(TIF)
Figure S6 Fragment length profile from digestion of
formaldehyde-treated dsDNA with exonuclease III as a
function of time. FAM-labeled 180 bp IGFBP1 DNA was
pretreated with 0.75% (v/v) formaldehyde for 10 min. The excess
formaldehyde was diluted and buffer exchanged before exonucle-
ase III digestion. Two units of exonuclease III were used to digest
the DNA for 0, 5 and 15 min at room temperature. The digestion
profile was visualized by application of the product solution onto
DNA tiling arrays and imaging the substrate on a fluorescence
scanner. The line profile directly below the tiling array images
contains average intensities for the first 90 of 162 unique array
features. Fluorescence signal from the remaining features was at
background levels.
(TIF)
Figure S7 Fragment length profile from digestion of
formaldehyde-treated and Tris-quenched dsDNA with
exonuclease III as a function of time. FAM-labeled 180 bp
IGFBP1 DNA was pretreated with 0.75% (v/v) formaldehyde for
10 min and quenched with 250 mM Tris. The formaldehyde and
Tris were diluted and buffer exchanged before exonuclease III
digestion. Two units of exonuclease III were used to digest the
DNA for 0, 5 and 15 min at room temperature. The digestion
profile was visualized by application of the product solution onto
DNA tiling arrays and imaging the substrate on a fluorescence
scanner. The line profile directly below the tiling array images
contains average intensities for the first 90 of 162 unique array
features. Fluorescence signal from the remaining features was at
background levels.
(TIF)
Figure S8 Fragment length profile from digestion of
formaldehyde-treated and glycine-quenched dsDNA
with exonuclease III as a function of time. FAM-labeled
180 bp IGFBP1 DNA was pretreated with 0.75% (v/v) formal-
dehyde for 10 min and quenched with 250 mM glycine. The
formaldehyde and glycine were diluted and buffer exchanged
before exonuclease III digestion. Two units of exonuclease III
were used to digest the DNA for 0, 5 and 15 min at room
temperature. The digestion profile was visualized by application of
the product solution onto DNA tiling arrays and imaging the
substrate on a fluorescence scanner. The line profile directly below
the tiling array images contains average intensities for the first 90
of 162 unique array features. Fluorescence signal from the
remaining features was at background levels.
(TIF)
Figure S9 Fragment length profile from digestion of
dsDNA with exonuclease III as a function of time and
enzyme dosage. The digestion profile was visualized by
application of the product solution onto DNA tiling arrays and
imaging the chip on a fluorescence scanner. (A) FAM-labeled
IGFBP1 DNA treated for 0, 1, 2, 5 and 15 min with 0.2 units of
exonuclease III at room temperature. (B) FAM-labeled IGFBP1
DNA treated for 0, 1, 2, 5 and 15 min with 2 units of exonuclease
III at room temperature. (C) FAM-labeled IGFBP1 DNA treated
for 0, 1, 2, 5 and 15 min with 20 units of exonuclease III at room
temperature. The line profile directly below the tiling array images
contains average intensities for the first 90 of 162 unique array
features. Fluorescence signal from the remaining features was at
background levels.
(TIF)
Figure S10 Fragment length profile from digestion of
FoxO1-IGFBP1 with exonuclease III as a function of time
and enzyme dosage. The digestion profile was visualized by
application of the product solution onto DNA tiling arrays and
imaging the chip on a fluorescence scanner. (A) FAM-labeled
IGFBP1 DNA in complex with FoxO1 protein treated for 0, 1, 2,
5 and 15 min with 0.2 units of exonuclease III at room
temperature. (B) Complex treated for 0, 1, 2, 5 and 15 min with
2 units of exonuclease III at room temperature. (C) Complex
treated for 0, 1, 2, 5 and 15 min with 20 units of exonuclease III at
room temperature. The line profile directly below the tiling array
images contains average intensities for the first 90 of 162 unique
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was at background levels.
(TIF)
Figure S11 Fragment length profile from digestion of
dsDNA with 0.2 units of exonuclease III as a function of
time. Exonuclease III was used to digest 100 ng FAM-labeled
IGFBP1 DNA for 0, 1, 2, 5 and 15 min at room temperature.
Exonuclease III digestions were stopped by addition of EDTA to a
final concentration of 25 mM. The samples were subjected to
fragment analysis using an ABI 3130xl Genetic Analyzer (Applied
Biosystems, CA, USA).
(TIF)
Figure S12 Fragment length profile from digestion of
dsDNA with 2 units of exonuclease III as a function of
time. Exonuclease III was used to digest 100 ng FAM-labeled
IGFBP1 DNA for 0, 1, 2, 5, and 15 min at room temperature.
Exonuclease III digestions were stopped by addition of EDTA to a
final concentration of 25 mM. The samples were then subjected to
fragment analysis using an ABI 3130xl Genetic Analyzer (Applied
Biosystems, CA, USA).
(TIF)
Figure S13 Fragment length profile from digestion of
dsDNA with 20 units of exonuclease III as a function of
time. Exonuclease III was used to digest 100 ng FAM-labeled
IGFBP1 DNA for 0, 1, 2, 5, and 15 min at room temperature.
Exonuclease III digestions were stopped by addition of EDTA to a
final concentration of 25 mM. The samples were then subjected to
fragment analysis using an ABI 3130xl Genetic Analyzer (Applied
Biosystems, CA, USA).
(TIF)
Figure S14 Fragment length profile from digestion of
formaldehyde-treated FoxO1-IGFBP1 with 2 units of
exonuclease III as a function of time and temperature.
Exonuclease III was used to digest 100 ng (DNA weight) FAM-
labeled FoxO1-IGFBP1 complex pre-treated with 0.75% (v/v)
formaldehyde for 0, 15, 45, and 120 min at 37uC as well as 45 min
at room temperature. The digested complex was treated by
proteinase K for 2 h at 65uC followed by cross-linking reversal in
250 mM Tris, pH 8.8, 0.5 M b-mercaptoethanol, and 2% SDS at
99uC for 25 min. The samples were then subjected to fragment
analysis using an ABI 3130xl Genetic Analyzer (Applied
Biosystems, CA, USA).
(TIF)
Figure S15 Fragment length profile from digestion of
formaldehyde-treated FoxO1-IGFBP1 with 20 units of
exonuclease III as a function of time and temperature.
Exonuclease III was used to digest 100 ng (DNA weight) FAM-
labeled FoxO1-IGFBP1 complex pre-treated with 0.75% (v/v)
formaldehyde for 0, 15, 45, and 120 min at 37uC. The digested
complex was treated by proteinase K for 2 h at 65uC followed by
cross-linking reversal in 250 mM Tris, pH 8.8, 0.5 M b-
mercaptoethanol, and 2% SDS at 99uC for 25 min. The samples
were then subjected to fragment analysis using an ABI 3130xl
Genetic Analyzer (Applied Biosystems, CA, USA).
(TIF)
Text S1 Sequence of IGFBP1 promoter region (225 to
2204) PCR amplicon (59R39). Character bordered sequences
show the primers used for PCR amplification. Underlined
sequences indicate FoxO1 binding sites including the FNBS
(FoxO1 new binding site, 59-ACAAACA-39, described previously
in Hatta et al. 2007) and two sites located in the IRE (insulin
response element).
(PDF)
Table S1 Target peptides for SRM analysis.
(DOC)
Table S2 The effects of cross-linking and cross-linking
reversal on mass spectrometric analysis of the FoxO1-
DNA complex using the SRM assay.
(DOC)
Table S3 Data Table for Discovery Mode Analysis of
FoxO1 Protein Captured on Solid Supports Modified
with Complementary and Non-Complementary (control)
Capture Oligonucleotides.
(DOC)
Table S4 Oligonucleotide sequences on the DNA arrays.
(DOC)
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